Oppenheimer Asset Management Inc. Royalty Pharma PLC Transaction History
Oppenheimer Asset Management Inc.
- $8.74 Billion
- Q3 2025
Shares
2 transactions
Others Institutions Holding RPRX
# of Institutions
508Shares Held
309MCall Options Held
1.99MPut Options Held
384K-
Morgan Stanley New York, NY46.6MShares$1.9 Billion0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA36.4MShares$1.48 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$939 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA21.9MShares$892 Million0.14% of portfolio
-
Baillie Gifford & CO17.4MShares$708 Million0.48% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $17.8B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...